TGF-β-Induced TMEPAI Promotes Epithelial–Mesenchymal Transition in Doxorubicin-Treated Triple-Negative Breast Cancer Cells via SMAD3 and PI3K/AKT Pathway Alteration

TGF-β-Induced TMEPAI Promotes Epithelial–Mesenchymal Transition in Doxorubicin-Treated Triple-Negative Breast Cancer Cells via SMAD3 and PI3K/AKT Pathway Alteration

Bantari WK Wardhani,1,2 Melva Louisa,3 Yukihide Watanabe,4 Rianto Setiabudy,3 Mitsuyasu Kato4 1Biomedical Sciences, Faculty of Medicine Universitas Indonesia, Jakarta, Indonesia; 2Department of Pharmacology, Faculty of Military Pharmacy, Indonesia Defense University, West Java, Indonesia; 3Departmen...

Full description

Bibliographic Details
Main Authors: Wardhani BWK, Louisa M, Watanabe Y, Setiabudy R, Kato M
Format: Article
Language:English
Published: Dove Medical Press 2021-09-01
Series:Breast Cancer : Targets and Therapy
Subjects:
pmepai
tgf-
smad3
vimentin
e-cadherin
drug efflux transporters
Online Access:https://www.dovepress.com/tgf--induced-tmepai-promotes-epithelialmesenchymal-transition-in-doxor-peer-reviewed-fulltext-article-BCTT

Internet

https://www.dovepress.com/tgf--induced-tmepai-promotes-epithelialmesenchymal-transition-in-doxor-peer-reviewed-fulltext-article-BCTT

Similar Items